GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
NEURALSTEM INC (CUR) [hlAlert]

Rating:
Sell CUR
down 63.51 %

NEURALSTEM INC (CUR) rated Sell with price target $0.25 by Maxim Group

Posted on: Thursday,  Aug 23, 2012  10:25 AM ET by Maxim Group

Maxim Group rated Sell NEURALSTEM INC (NASDAQ: CUR) on 08/23/2012, when the stock price was $0.54. Since
then, NEURALSTEM INC has gained 174.07% as of 01/14/2016's recent price of $1.48.
If you would have followed this Maxim Group's recommendation on CUR, you would have lost 63.51% of your investment in 1239 days.

Neuralstem, Inc. is a biotechnology company focused on developing and commercializing human neural stem cell technology in the field of regenerative medicine. The Company manufactures its cells both in-house and on an outsource basis. It uses these cells in its research grant and collaborative programs. The Company outsources all the manufacturing and storage of its stem cells to be used in pre-clinical works to Charles River Laboratories, Inc., of Wilmington, Massachusetts. The Charles River facility has the capacity to be used for cell processing under the United States Food and Drug Administration (FDA) determined good manufacturing practices (GMP) in quantities sufficient for its current pre-trial and anticipated future clinical trial needs. As of December 31, 2008, the Company had not identified any specific product.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/23/2012 10:25 AM Sell
None
0.54 0.25
as of 12/31/2012
1 Week up  2.67 %
1 Month up  12.80 %
3 Months up  12.80 %
1 YTD down  -101.85 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy